Kore Private Wealth LLC Crispr Therapeutics Ag Transaction History

Kore Private Wealth LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $21,038 - $26,971	-268 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $10,318 - $20,381	268 New	268 $19,000
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $26,303 - $35,764	-742 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$28.02 - $40.87 $28,020 - $40,870	-1,000 Reduced 57.41%	742 $27,000
Q4 2018 May 23, 2019	BUY	$22.73 - $42.34 $39,595 - $73,756	1,742 New	1,742 $50,000

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.